320 related articles for article (PubMed ID: 31367788)
1. The thioredoxin system and cancer therapy: a review.
Mohammadi F; Soltani A; Ghahremanloo A; Javid H; Hashemy SI
Cancer Chemother Pharmacol; 2019 Nov; 84(5):925-935. PubMed ID: 31367788
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Thioredoxin System for Cancer Therapy.
Zhang J; Li X; Han X; Liu R; Fang J
Trends Pharmacol Sci; 2017 Sep; 38(9):794-808. PubMed ID: 28648527
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
Tonissen KF; Di Trapani G
Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
[TBL] [Abstract][Full Text] [Related]
4. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
Huang J; Xu J; Tian L; Zhong L
Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
[TBL] [Abstract][Full Text] [Related]
5. Role of thioredoxin in lung disease.
Xu J; Li T; Wu H; Xu T
Pulm Pharmacol Ther; 2012 Apr; 25(2):154-62. PubMed ID: 22293327
[TBL] [Abstract][Full Text] [Related]
6. The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy.
Biaglow JE; Miller RA
Cancer Biol Ther; 2005 Jan; 4(1):6-13. PubMed ID: 15684606
[TBL] [Abstract][Full Text] [Related]
7. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase.
Hashemy SI; Ungerstedt JS; Zahedi Avval F; Holmgren A
J Biol Chem; 2006 Apr; 281(16):10691-7. PubMed ID: 16481328
[TBL] [Abstract][Full Text] [Related]
8. The thioredoxin antioxidant system.
Lu J; Holmgren A
Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
[TBL] [Abstract][Full Text] [Related]
9. Potential Anticancer Activity of Auranofin.
Onodera T; Momose I; Kawada M
Chem Pharm Bull (Tokyo); 2019; 67(3):186-191. PubMed ID: 30827998
[TBL] [Abstract][Full Text] [Related]
10. Overview of thioredoxin system and targeted therapies for acute leukemia.
Xie W; Ma W; Liu P; Zhou F
Mitochondrion; 2019 Jul; 47():38-46. PubMed ID: 31029641
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic characterization of the thioredoxin system in the removal of hydrogen peroxide.
Pannala VR; Dash RK
Free Radic Biol Med; 2015 Jan; 78():42-55. PubMed ID: 25451645
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione.
Lu J; Vlamis-Gardikas A; Kandasamy K; Zhao R; Gustafsson TN; Engstrand L; Hoffner S; Engman L; Holmgren A
FASEB J; 2013 Apr; 27(4):1394-403. PubMed ID: 23248236
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin system modulation by plant and fungal secondary metabolites.
Dal Piaz F; Braca A; Belisario MA; De Tommasi N
Curr Med Chem; 2010; 17(5):479-94. PubMed ID: 19941471
[TBL] [Abstract][Full Text] [Related]
14. Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples.
Montano SJ; Lu J; Gustafsson TN; Holmgren A
Anal Biochem; 2014 Mar; 449():139-46. PubMed ID: 24374250
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin reductase as a pharmacological target.
Bjørklund G; Zou L; Wang J; Chasapis CT; Peana M
Pharmacol Res; 2021 Dec; 174():105854. PubMed ID: 34455077
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents.
Liu Y; Li Y; Yu S; Zhao G
Curr Drug Targets; 2012 Oct; 13(11):1432-44. PubMed ID: 22876886
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma.
Kahlos K; Soini Y; Säily M; Koistinen P; Kakko S; Pääkkö P; Holmgren A; Kinnula VL
Int J Cancer; 2001 May; 95(3):198-204. PubMed ID: 11307155
[TBL] [Abstract][Full Text] [Related]
18. Expression and distribution of thioredoxin and thioredoxin reductase in human nasal mucosa and nasal polyp.
Lee SH; Kim WS; Lee SH; Oh JW; Lee HM; Jung HH; Jang JW; Jun YJ; Cho WJ; Jhun HS
Acta Otolaryngol; 2005 Aug; 125(8):877-82. PubMed ID: 16158536
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system.
Nordberg J; Arnér ES
Free Radic Biol Med; 2001 Dec; 31(11):1287-312. PubMed ID: 11728801
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin and thioredoxin reductase: current research with special reference to human disease.
Holmgren A; Lu J
Biochem Biophys Res Commun; 2010 May; 396(1):120-4. PubMed ID: 20494123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
